TerSera Therapeutics Discontinued
FDA Approved Drugs

TerSera Therapeutics Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 3
  • Latest Approval Date Oct 19, 2018
  • Data Source FDA
  • First Approval Date Oct 25, 2017
All
7
View
Discontinued
3
View
RX
4
View
Company Overview

Company

TerSera Therapeutics Discontinued

Country

U.S.A

Website

Visit Website

Email

medicalinformation@tersera.com

Social Profiles

Company Snapshot

TerSera Therapeutics Discontinued

520 Lake Cook Rd, Suite 500, Deerfield, Illinois 60015

U.S.A

www.tersera.com/ medicalinformation@tersera.com View on Map
FDA Approved Drug Records ( 3 records )
2018
19 Oct
Discontinued Application: 211210

Drug Name

QMIIZ ODT

Product Number

1

Dosage Form

-

Strength

7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2018-10-19

211210 / 1

Active Ingredient

MELOXICAM

Application Number

211210

Product Number

1

Dosage Form

-

Strength

7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2018-10-19

Regulatory Status

Discontinued

2018
19 Oct
Discontinued Application: 211210

Drug Name

QMIIZ ODT

Product Number

2

Dosage Form

-

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2018-10-19

211210 / 2

Active Ingredient

MELOXICAM

Application Number

211210

Product Number

2

Dosage Form

-

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2018-10-19

Regulatory Status

Discontinued

2017
25 Oct
Discontinued Application: 208399

Drug Name

VARUBI

Product Number

1

Dosage Form

-

Strength

EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML)

Approval Date

2017-10-25

208399 / 1

Active Ingredient

ROLAPITANT HYDROCHLORIDE

Application Number

208399

Product Number

1

Dosage Form

-

Strength

EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML)

Approval Date

2017-10-25

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    1 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    7 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
3 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

QMIIZ ODT

Application Number

211210

Product Number

1

Active Ingredient

MELOXICAM

Dosage Form

-

Strength

7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit